FR2320736B1 - - Google Patents

Info

Publication number
FR2320736B1
FR2320736B1 FR7624440A FR7624440A FR2320736B1 FR 2320736 B1 FR2320736 B1 FR 2320736B1 FR 7624440 A FR7624440 A FR 7624440A FR 7624440 A FR7624440 A FR 7624440A FR 2320736 B1 FR2320736 B1 FR 2320736B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7624440A
Other languages
French (fr)
Other versions
FR2320736A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Publication of FR2320736A1 publication Critical patent/FR2320736A1/fr
Application granted granted Critical
Publication of FR2320736B1 publication Critical patent/FR2320736B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Oncology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pyridine Compounds (AREA)
FR7624440A 1975-08-11 1976-08-10 Derives de guanidine Granted FR2320736A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB33435/75A GB1492678A (en) 1975-08-11 1975-08-11 Guanidine derivatives

Publications (2)

Publication Number Publication Date
FR2320736A1 FR2320736A1 (fr) 1977-03-11
FR2320736B1 true FR2320736B1 (xx) 1980-11-07

Family

ID=10352924

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7624440A Granted FR2320736A1 (fr) 1975-08-11 1976-08-10 Derives de guanidine

Country Status (17)

Country Link
JP (1) JPS5225743A (xx)
AT (1) AT351045B (xx)
AU (1) AU497534B2 (xx)
BE (1) BE845052A (xx)
CA (1) CA1087180A (xx)
CH (1) CH625207A5 (xx)
DE (1) DE2635932A1 (xx)
DK (1) DK362576A (xx)
FI (1) FI762158A (xx)
FR (1) FR2320736A1 (xx)
GB (1) GB1492678A (xx)
IE (1) IE43488B1 (xx)
NL (1) NL7608903A (xx)
NO (1) NO143993C (xx)
PL (1) PL98956B1 (xx)
SE (1) SE7608929L (xx)
ZA (1) ZA764126B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA829068B (en) * 1980-07-01 1983-02-23 Nat Res Dev Prostaglandins
EP0082646B1 (en) * 1981-12-23 1989-11-15 National Research Development Corporation Prostaglandins
DE3249514T1 (de) * 1982-06-21 1984-05-17 Institut organičeskogo sinteza Akademii Nauk Latvijskoj SSR, Riga Arzneimittel mit antikarzinogener Wirkung
WO2005095345A2 (en) * 2004-03-23 2005-10-13 Achillion Pharmaceuticals, Inc. Heteroaryl guanidines as inhibitors of viral replication

Also Published As

Publication number Publication date
FR2320736A1 (fr) 1977-03-11
CH625207A5 (en) 1981-09-15
CA1087180A (en) 1980-10-07
BE845052A (fr) 1977-02-10
NO143993B (no) 1981-02-16
IE43488B1 (en) 1981-03-11
PL98956B1 (pl) 1978-06-30
ZA764126B (en) 1977-06-29
AT351045B (de) 1979-07-10
IE43488L (en) 1977-02-11
GB1492678A (en) 1977-11-23
SE7608929L (sv) 1977-02-12
NO143993C (no) 1981-05-27
JPS5225743A (en) 1977-02-25
AU497534B2 (en) 1978-12-14
AU1595676A (en) 1978-01-19
DE2635932A1 (de) 1977-03-03
DK362576A (da) 1977-02-12
NL7608903A (nl) 1977-02-15
NO762774L (xx) 1977-02-14
FI762158A (xx) 1977-02-12
ATA592976A (de) 1978-12-15

Similar Documents

Publication Publication Date Title
FR2320736B1 (xx)
JPS5629536B2 (xx)
JPS5740986B2 (xx)
JPS538834B2 (xx)
JPS5632667B2 (xx)
JPS5526367B2 (xx)
JPS5231102U (xx)
JPS5227627U (xx)
JPS5219444U (xx)
JPS5339323Y2 (xx)
JPS5721878Y2 (xx)
JPS5271540U (xx)
CH604374A5 (xx)
CH609955A5 (xx)
BG22526A1 (xx)
BG22319A1 (xx)
CH201875A4 (xx)
BG22245A1 (xx)
CH376676A4 (xx)
CH577128A5 (xx)
CH607238A5 (xx)
CH592404A5 (xx)
BG22115A1 (xx)
CH577352A5 (xx)
CH579854A5 (xx)

Legal Events

Date Code Title Description
ST Notification of lapse